Join the Endocrine Society for a timely discussion on the economic burden of diabetes and the anticipated impact of the Patient Protection and Affordable Care Act (ACA) on patient care. Leaders from the NIH, CDC, academia and industry will explore the benefits and challenges the ACA poses for people with diabetes.
This policy summit will explore:
-
The current state of diabetes care in the United States, including its epidemiology, prevalence, and challenges relevant to care management.
-
The cost of diabetes care and the impact on various stakeholder groups, including individual patients, third-party payers, and health care systems.
-
Intended benefits of the ACA and how this shift in health care policy may impact diabetes care and outcomes.
Invited speakers include White House officials, congressional staff, diabetes experts, payers, key policymakers, and more.
Date & time:
September 12, 2014
9 a.m – 4 p.m.
Washington, DC
Location:
Ronald Reagan Building and International Trade Center – Atrium
1300 Pennsylvania Avenue, NW
Washington, DC 20004
Visit The Endocrine Society for more information, or contact Aaron Lohr at alohr@endocrine.org or 202.971.3654 , or Jenni Gingery at jgingery@endocrine.org or 202.971.3655.